Corona situation: Vaccination order could be canceled from mid-June

Health Minister Jens Spahn, Vice President of the Robert Koch Institute Lars Schaade and President of the Paul Ehrlich Institute Klaus Cichutek comment on the current corona situation.

Health Minister Jens Spahn continues to point to overworked intensive care units and hospitals, but gives hope.

Vaccination order could be reversed from mid-June

Despite the rising incidence figures and the overburdening of hospitals, Health Minister Jens Spahn gives hope in today’s press conference in the Corona crisis: The vaccination order is to be lifted from mid-June. However, Spahn also points out that not all citizens can be offered a vaccination immediately. This could be done by the end of the summer.

However, examples from other countries showed that increased  vaccination progress  could not prevent a third wave.

The Minister of Health continues to warn against high incidence figures, since an increased incidence currently also means a high burden on hospitals. Contact restrictions, social distancing and other points of the Corona emergency brake should therefore continue to be observed in order to keep the numbers down.

Long-COVID is also a concern

According to RKI Vice President Lars Schaade, 80 percent of the current corona patients in hospitals have to be ventilated, and an increasing number of younger patients on the artificial lung. In addition to the current diseases, the  long-COVID syndrome is also a cause for concern: According to current studies, up to 10 percent of patients could  suffer from the long-term consequences of corona ,  even with mild courses  . According to Schaade, these include:

  • neurological disorders
  • fatigue
  • difficulty concentrating

Schaade continues to appeal to the solidarity of the Germans: “Let’s give everyone the chance to get this vaccination, let’s continue to act in solidarity.”

Four more vaccines give hope

The President of the Paul Ehrlich Institute, Klaus Cichutek, points out that there has seldom been so much data collected so early on the effectiveness and safety of the vaccines. The assessment of the effectiveness against severe COVID courses is very high for all approved vaccines and could also help against mutations. The spread of the virus can also be significantly reduced.

In addition to  Johnson  & Johnson, the vaccines from CureVac, Novavax and  Sputnik V are also  in the starting blocks – the vaccines could be approved in 2021.

Furthermore, the first study results on the effect of vaccines in children are already available. The first approvals for the corona vaccine for children and adolescents could take place as early as the beginning of 2022.


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *